1-氯-2,3,4,5-四甲基-苯 | 26138-77-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-氯-2,3,4,5-四甲基-苯
• 英文名称: 1-chloro-2,3,4,5-tetramethyl-benzene
• 英文别名: 1-Chlor-2,3,4,5-tetramethyl-benzol；Chlor-pre..nitol；Chlorprehnitol；1-Chloro-2,3,4,5-tetramethylbenzene
• CAS: 26138-77-2
• 化学式: C₁₀H₁₃Cl
• 分子量: 168.666
• InChiKey: XBGOUJALJVZXEF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  1-氯-2,3,4,5-四甲基-苯 在 硝酸 作用下， 生成 5-chloro-benzene-1,2,3,4-tetracarboxylic acid
  参考文献：
  名称：

  Horner; Spietschka, Justus Liebigs Annalen der Chemie, 1953, vol. 579, p. 159,161

  摘要：

  DOI：
• 作为产物：
  描述：

  四甲基萘 在 benzyltrimethylazanium tetrachloro-λ³-iodanuide 作用下， 以 溶剂黄146 为溶剂， 反应 20.0h， 以76%的产率得到1-氯-2,3,4,5-四甲基-苯
  参考文献：
  名称：

  使用季铵多卤化物的卤化。十九。苄基三甲基四氯碘酸铵对芳烃的芳香氯化

  摘要：

  在室温或 70 °C 下，芳烃与计算量的四氯碘酸苄基铵和乙酸反应，以相当好的产率得到核氯取代的芳烃。

  DOI：

  10.1246/bcsj.62.2096

文献信息

• Orientation of the Products from the Nitration of Halopentamethylbenzenes
  作者：Hitomi Suzuki

  DOI：10.1246/bcsj.43.481

  日期：1970.2

  5-Halo-2,3,4,6-tetramethyl- and 6-halo-2,3,4,5-tetramethylbenzyl nitrate were the principal products. 4-Halo-2,3,5,6-tetramethylbenzyl nitrate was never formed in any significant amount. The orientation was consistent with the previously suggested mechanistic scheme. PMR spectral data for nine halotetramethylbenzyl chlorides and nitrates have been presented.

  已经研究了发烟硝酸对氯五甲基苯、溴五甲基苯和碘五甲基苯的作用。主要产品为硝酸5-卤-2,3,4,6-四甲基-及6-卤-2,3,4,5-四甲基苄基硝酸酯。4-Halo-2,3,5,6-四甲基苄基硝酸盐从未以任何显着量形成。方向与先前建议的机械方案一致。已经提供了九种卤代四甲基苄基氯和硝酸盐的 PMR 光谱数据。
• Syntheses of Diiodo and Triiodo Derivatives of 1,2,3-Trimethylbenzene (<i>Hemimellitene</i>) and 1,2,4-Trimethylbenzene (<i>Pseudocumene</i>). A Convenient Use of Polyiodo Derivatives for the Characterization of Polyalkylbenzenes and Their Derivatives
  作者：Hitomi Suzuki、Yasuhiro Haruta

  DOI：10.1246/bcsj.46.589

  日期：1973.2

  A complete set of diiodo and triiodo derivatives of 1,2,3-trimethylbenzene and 1,2,4-trimethylbenzene has been prepared and their physical properties are recorded. Use of polyiodo derivatives as a means for characterizing polyalkylbenzenes and their derivatives has been proposed.

  制备了一套完整的1,2,3-三甲基苯和1,2,4-三甲基苯的二碘和三碘衍生物并记录了它们的物理性质。已经提出使用多碘衍生物作为表征多烷基苯及其衍生物的手段。
• Structure Proof of Diarylmethanes Formed in the Jacobsen Reaction of Monochlorotetramethylbenzenes
  作者：Hitomi Suzuki

  DOI：10.1246/bcsj.42.2618

  日期：1969.9

  The Jacobsen reaction of monochlorotetramethylbenzenes was found to yield dichloroheptamethyldiphenylmethanes as by-product. Their indefinite structure proof was made on spectroscopy and synthesis. 1H NMR spectra for a variety of polymethyldiphenylmethanes and their chlorine derivatives were determined.

  发现一氯四甲基苯的 Jacobsen 反应产生作为副产物的二氯七甲基二苯基甲烷。它们的不确定结构证明是在光谱和合成上进行的。测定了多种聚甲基二苯基甲烷及其氯衍生物的 1 H NMR 光谱。
• DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES
  申请人：OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES"

  公开号：US20160031858A1

  公开（公告）日：2016-02-04

  The present invention relates to novel biologically active compounds, in particular dicarboxylic acid bisamide derivatives of general formula I: or pharmaceutically acceptable salts thereof, which are able to form complexes with or chelate metal ions. The invention also relates to the use of said compounds as an agent for the prevention and/or treatment of cardiovascular, viral, cancer, neurodegenerative and inflammatory diseases, diabetes, age-related diseases, diseases caused by microbial toxins, alcoholism and alcoholic cirrhosis, anaemia, porphyria cutanea tarda, and transition metal salt poisoning. The present invention also relates to novel methods for preparing dicarboxylic acid bisamide derivatives of general formula I.

  本发明涉及一种新型生物活性化合物，特别是一般式I的二羧酸双酰胺衍生物，或其药学上可接受的盐，能够与金属离子形成络合物或螯合物。该发明还涉及所述化合物作为预防和/或治疗心血管、病毒性、癌症、神经退行性和炎症性疾病、糖尿病、与年龄相关的疾病、微生物毒素引起的疾病、酗酒和酒精性肝硬化、贫血、皮肤坏疽性卟啉病和过渡金属盐中毒的药剂。本发明还涉及制备一般式I的二羧酸双酰胺衍生物的新方法。
• AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES
  申请人：OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES"

  公开号：US20170183318A1

  公开（公告）日：2017-06-29

  The present invention relates to medicine and includes a method for preventing and treating diseases caused by RNA- and DNA-containing viruses, and concomitant diseases, wherein the method comprises the use of an effective amount of compounds of general formula I or pharmaceutically acceptable salts thereof. The invention also relates to methods for preparing said compounds, pharmaceutical compositions for the prevention or treatment of diseases caused by RNA- and DNA-containing viruses, said compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof. The invention addresses the object of providing a novel agent effective in the treatment of diseases caused by an RNA-containing virus belonging to the Enterovirus, Metapneumovirus, Pneumovirus, Respirovirus, or Alfa-coronavirus genus, and/or by a DNA-containing virus belonging to the Adenoviridae and/or Herpesviridae family, and in the prevention and treatment of asthma exacerbation, chronic obstructive pulmonary disease, mucoviscidosis, conjunctivitis, gastroenteritis, hepatitis, myocarditis; in the prevention and treatment of rhinorrhea, acute and infectious rhinitis, pharyngitis, nasopharyngitis, tonsillitis, laryngitis, laryngotracheitis, laryngotracheobronchitis, bronchitis, bronchiolitis, pneumonia, or airway obstructive syndrome.

  本发明涉及医学，包括一种用于预防和治疗由RNA-和DNA-含病毒引起的疾病以及相关疾病的方法，其中该方法包括使用通式I的化合物或其药用可接受盐的有效量。该发明还涉及制备上述化合物的方法，用于预防或治疗由RNA-和DNA-含病毒引起的疾病的药物组合物，该组合物包括通式I的化合物或其药用可接受盐的有效量。该发明解决了提供一种新型药剂的目标，用于治疗属于肠病毒、副呼吸道病毒、呼吸道病毒、呼吸道病毒或阿尔法冠状病毒属的RNA-含病毒引起的疾病，和/或属于腺病毒科和/或疱疹病毒科的DNA-含病毒引起的疾病，并在预防和治疗哮喘急性发作、慢性阻塞性肺疾病、黏液囊病、结膜炎、胃肠炎、肝炎、心肌炎；在预防和治疗流涕、急性和感染性鼻炎、咽炎、鼻咽炎、扁桃体炎、喉炎、喉气管炎、喉气管支气管炎、支气管炎、支气管炎、肺炎或气道梗阻综合征方面具有有效性。